Usual interstitial pneumonia: a clinically significant pattern, but not the final word.

Area of Science:

• Pulmonary Pathology
• Interstitial Lung Diseases
• Diagnostic Criteria

Background:

• Usual interstitial pneumonia (UIP) is a widely used diagnostic term for fibrotic interstitial lung disease (ILD), but its prognostic significance is hampered by diagnostic ambiguity and poor inter-observer agreement.
• The evolving landscape of anti-fibrotic therapies necessitates a diagnostic approach that prioritizes identifying the underlying etiology of fibrosis over solely recognizing a specific pattern.
• Current diagnostic guidelines for ILD are difficult to apply, and the value of lung biopsies is diminishing as pathological assessment insufficiently informs therapeutic decision-making.

Purpose of the Study:

• To critically evaluate the limitations of the current UIP diagnostic concept in fibrotic interstitial lung disease (ILD).
• To advocate for a paradigm shift in pathological assessment of ILD biopsies, focusing on etiological diagnosis to guide anti-fibrotic therapy.
• To emphasize the need for developing new, evidence-based, and clinically relevant diagnostic criteria for ILD.

Main Methods:

• Review and critical analysis of the current understanding and application of the UIP diagnostic term in fibrotic ILD.
• Discussion of the impact of anti-fibrotic agents on diagnostic priorities in ILD.
• Exploration of the role of pathologists in improving the diagnostic value of lung biopsies for ILD patient management.

Main Results:

• The term UIP is prone to misinterpretation and lacks a definitive gold standard for diagnosing fibrotic ILD.
• Pulmonologists are increasingly hesitant to perform biopsies due to the perceived insufficient value and reliability of pathological assessment in guiding therapy.
• A shift in diagnostic focus towards identifying the most likely etiology of fibrosis is crucial for selecting appropriate anti-fibrotic treatments.

Conclusions:

• Pathologists must acknowledge the limitations of the UIP concept to enhance the diagnostic value of ILD biopsies.
• The primary goal of ILD biopsy should be etiological determination to inform targeted therapy, necessitating a change in diagnostic focus.
• Development and validation of novel, evidence-based classification systems and criteria are essential for advancing the diagnosis and management of fibrotic ILDs.